Akita Hidetaka, Noguchi Yuki, Hatakeyama Hiroto, Sato Yusuke, Tange Kota, Nakai Yuta, Harashima Hideyoshi
Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Science, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, Japan.
NOF Corporation, 3-3 Chidori-cho, Kawasaki-ku, Kawasaki, Kanagawa 210-0865, Japan.
ACS Biomater Sci Eng. 2015 Sep 14;1(9):834-844. doi: 10.1021/acsbiomaterials.5b00203. Epub 2015 Aug 20.
A lipid nanoparticle (LNP) composed of a series of SS-cleavable and pH-activated lipid-like materials (ssPalm) was previously developed as a platform of a gene delivery system. A tertiary amine and disulfide bonding were employed to destabilize the endosomal membrane and for intracellular collapse. We report herein on the development of a hepatocyte-targeting siRNA carrier by the molecular tuning of the hydrophobic scaffold, and tertiary amine structures. The gene knockdown activity against a hepatocyte-specific marker (factor VII: FVII) was improved when a more fat-soluble vitamin (vitamin E) was employed as a hydrophobic scaffold. Moreover, to allow the tertiary amines to accept protons by sensing a slight change in endosomal acidification, its structural flexibility was minimized by fixing it in a piperidine structure, and the distance between the surface of the particle to the ternary amine was increased. As a result, the p value was increased to the approximately 6.18 depending on its distance, while the p reached plateau when the tertiary amine was linked by an excess number of linear carbon chains. The pH-dependent membrane destabilization activity, as assessed by a hemolysis assay, was increased in parallel with the p value. Moreover, the gene knockdown activity was improved in parallel with hemolytic activity. Finally, further optimization of the lipid/siRNA ratio, and the use of chemically (2'-fluoro) modified siRNA synergistically improved the gene knockdown efficacy to an effective dose (ED) of 0.035 mg/kg. The developed ssPalm represents a promising platform for use as a hepatocyte-targeting siRNA carrier.
一种由一系列可被SS切割且对pH敏感的类脂质材料(ssPalm)组成的脂质纳米颗粒(LNP)先前已被开发为基因递送系统的平台。使用叔胺和二硫键来破坏内体膜的稳定性并实现细胞内崩解。我们在此报告通过对疏水支架和叔胺结构进行分子调控来开发一种肝细胞靶向性siRNA载体。当使用更具脂溶性的维生素(维生素E)作为疏水支架时,针对肝细胞特异性标志物(因子VII:FVII)的基因敲低活性得到了提高。此外,为了使叔胺能够通过感知内体酸化的轻微变化来接受质子,通过将其固定在哌啶结构中来最小化其结构灵活性,并增加颗粒表面到叔胺的距离。结果,根据其距离,p值增加到约6.18,而当叔胺通过过量的线性碳链连接时,p达到平台期。通过溶血试验评估的pH依赖性膜破坏活性与p值平行增加。此外,基因敲低活性与溶血活性平行提高。最后,进一步优化脂质/siRNA比例以及使用化学修饰(2'-氟)的siRNA协同将基因敲低功效提高到有效剂量(ED)为0.035 mg/kg。所开发的ssPalm是一种有前景的用作肝细胞靶向性siRNA载体的平台。